CXCL9 Is a Potential Biomarker of Immune Infiltration Associated With Favorable Prognosis in ER-Negative Breast Cancer

CXCL9 Is a Potential Biomarker of Immune Infiltration Associated With Favorable Prognosis in ER-Negative Breast Cancer

The chemokine CXCL9 (C-X-C motif chemokine ligand 9) has been reported to be required for antitumour immune responses following immune checkpoint blockade. In this study, we sought to investigate the potential value of CXCL9 according to immune responses in patients with breast cancer (BC). A variet...

Full description

Bibliographic Details
Main Authors: Yuan-ke Liang, Ze-kun- Deng, Mu-tong Chen, Si-qi Qiu, Ying-sheng Xiao, Yu-zhu Qi, Qin Xie, Zheng-hao Wang, Shi-cheng Jia, De Zeng, Hao-yu Lin
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Oncology
Subjects:
breast cancer
CXCL9
biomarker
prognosis
immune infiltration
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.710286/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.710286/full

Similar Items